| High | P63085 | Mitogen-activated protein kinase 1 OS=Mus musculus OX=10090 GN=Mapk1 PE=1 SV=3 | 0 | 5.971 | 8 | 3 | 4 | 3 | 358 | 41.2 | 6.98 | 3 | | | | 4 | | | | 2124884.313 | 730451.1875 | 1033258.313 | 3072258.25 | 3 | 1 | 1 | 1 | Met-loss+Acetyl [N-Term] | cell communication;cell death;cell differentiation;cell proliferation;cellular homeostasis;metabolic process;regulation of biological process;response to stimulus;transport | cytoplasm;cytoskeleton;cytosol;endosome;Golgi;membrane;mitochondrion;nucleus | catalytic activity;nucleotide binding;protein binding;signal transducer activity | "Pf00069, Pf01636, Pf07714" | 26413 | ENSMUSG00000063358.15 | Mapk1 | 16 | "NCAM signaling for neurite out-growth; MAP2K and MAPK activation; Spry regulation of FGF signaling; Signal transduction by L1; FCERI mediated MAPK activation; phospho-PLA2 pathway; Regulation of HSF1-mediated heat shock response; Activated TLR4 signalling; Signaling by GPCR; Neutrophil degranulation; Gastrin-CREB signalling pathway via PKC and MAPK; MAPK1 (ERK2) activation; Recycling pathway of L1; Thrombin signalling through proteinase activated receptors (PARs); RHO GTPases Activate WASPs and WAVEs; Golgi Cisternae Pericentriolar Stack Reorganization; Interleukin-20 family signaling; RSK activation; Regulation of actin dynamics for phagocytic cup formation; Activation of the AP-1 family of transcription factors; Growth hormone receptor signaling; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Oxidative Stress Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); Oncogene Induced Senescence; ERKs are inactivated; Negative feedback regulation of MAPK pathway" | Oxytocin signaling pathway; ErbB signaling pathway; FoxO signaling pathway; Acute myeloid leukemia; AGE-RAGE signaling pathway in diabetic complications; mTOR signaling pathway; Cholinergic synapse; Platinum drug resistance; Chagas disease (American trypanosomiasis); T cell receptor signaling pathway; Phospholipase D signaling pathway; Retrograde endocannabinoid signaling; Regulation of actin cytoskeleton; MAPK signaling pathway; Type II diabetes mellitus; Progesterone-mediated oocyte maturation; Ras signaling pathway; Prolactin signaling pathway; TNF signaling pathway; VEGF signaling pathway; Focal adhesion; NOD-like receptor signaling pathway; Insulin signaling pathway; Endometrial cancer; Long-term potentiation; Toxoplasmosis; Chemokine signaling pathway; Breast cancer; Melanoma; Platelet activation; Signaling pathways regulating pluripotency of stem cells; Tuberculosis; Melanogenesis; Hepatitis B; Axon guidance; Oocyte meiosis; Osteoclast differentiation; Non-small cell lung cancer; Adherens junction; Sphingolipid signaling pathway; B cell receptor signaling pathway; Dorso-ventral axis formation; Glutamatergic synapse; Toll-like receptor signaling pathway; Pertussis; Proteoglycans in cancer; Salmonella infection; Fc gamma R-mediated phagocytosis; Thyroid hormone signaling pathway; Neurotrophin signaling pathway; Long-term depression; cGMP-PKG signaling pathway; TGF-beta signaling pathway; Rap1 signaling pathway; HIF-1 signaling pathway; Pathways in cancer; Influenza A; Hepatitis C; Alzheimer's disease; Alcoholism; Pancreatic cancer; Thyroid cancer; PI3K-Akt signaling pathway; cAMP signaling pathway; Vascular smooth muscle contraction; Renal cell carcinoma; GnRH signaling pathway; Natural killer cell mediated cytotoxicity; Prion diseases; Gap junction; Circadian entrainment; Glioma; Fc epsilon RI signaling pathway; EGFR tyrosine kinase inhibitor resistance; Leishmaniasis; Central carbon metabolism in cancer; Choline metabolism in cancer; Estrogen signaling pathway; Th1 and Th2 cell differentiation; Colorectal cancer; Viral carcinogenesis; Chronic myeloid leukemia; Serotonergic synapse; Adrenergic signaling in cardiomyocytes; Prostate cancer; Endocrine resistance; Bladder cancer; Aldosterone-regulated sodium reabsorption; Apoptosis | 0 |